BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8083967)

  • 1. Monocyte maturation controls expression of equine infectious anemia virus.
    Maury W
    J Virol; 1994 Oct; 68(10):6270-9. PubMed ID: 8083967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DH82 cells: a macrophage cell line for the replication and study of equine infectious anemia virus.
    Hines R; Maury W
    J Virol Methods; 2001 Jun; 95(1-2):47-56. PubMed ID: 11377712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phorbol ester stimulation of equine macrophage cultures alters expression of equine infectious anemia virus.
    Sellon DC; Walker KM; Russell KE; Perry ST; Fuller FJ
    Vet Microbiol; 1996 Oct; 52(3-4):209-21. PubMed ID: 8972047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.
    Hines R; Sorensen BR; Shea MA; Maury W
    J Virol; 2004 Apr; 78(7):3407-18. PubMed ID: 15016863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell specificity of the transcription-factor repertoire used by a lentivirus: motifs important for expression of equine infectious anemia virus in nonmonocytic cells.
    Maury W; Bradley S; Wright B; Hines R
    Virology; 2000 Feb; 267(2):267-78. PubMed ID: 10662622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes.
    Sellon DC; Perry ST; Coggins L; Fuller FJ
    J Virol; 1992 Oct; 66(10):5906-13. PubMed ID: 1382143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter.
    Carvalho M; Derse D
    J Virol; 1993 Jul; 67(7):3885-90. PubMed ID: 8389910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter.
    Carvalho M; Derse D
    J Virol; 1993 Apr; 67(4):2064-74. PubMed ID: 8383228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine endothelial cells support productive infection of equine infectious anemia virus.
    Maury W; Oaks JL; Bradley S
    J Virol; 1998 Nov; 72(11):9291-7. PubMed ID: 9765477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of equine infectious anemia virus expression.
    Maury W
    J Biomed Sci; 1998; 5(1):11-23. PubMed ID: 9570509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
    Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
    Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection.
    Chen C; Li F; Montelaro RC
    J Virol; 2001 Oct; 75(20):9762-70. PubMed ID: 11559809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
    Maury WJ; Carpenter S; Graves K; Chesebro B
    Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.
    Lichtenstein DL; Rushlow KE; Cook RF; Raabe ML; Swardson CJ; Kociba GJ; Issel CJ; Montelaro RC
    J Virol; 1995 May; 69(5):2881-8. PubMed ID: 7707512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.
    Harrold SM; Cook SJ; Cook RF; Rushlow KE; Issel CJ; Montelaro RC
    J Virol; 2000 Apr; 74(7):3112-21. PubMed ID: 10708426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus.
    Raabe MR; Issel CJ; Montelaro RC
    J Virol Methods; 1998 Mar; 71(1):87-104. PubMed ID: 9628225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity.
    Carvalho M; Kirkland M; Derse D
    J Virol; 1993 Nov; 67(11):6586-95. PubMed ID: 8411361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin treatment of equine infectious anaemia virus-infected horse macrophage cultures decreases production of infectious virus.
    Smith TA; Davis E; Carpenter S
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():747-55. PubMed ID: 9568970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats.
    Sherman L; Yaniv A; Lichtman-Pleban H; Tronick SR; Gazit A
    J Virol; 1989 Nov; 63(11):4925-31. PubMed ID: 2552171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
    Ji S; Na L; Ren H; Wang Y; Wang X
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.